ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,249.78
-2.47%
S&P 500
5,641.97
0.19%
Dow Jones
40,700.42
1.22%
US Dollar vs Yen
158.573
0.27%
Brent Oil
83.17
-1.39%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. CytomX Therapeutics Inc (CTMX)

  7. CytomX Therapeutics Inc (CTMX) ニュース

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CTMX
日付受信時刻ニュースソース見出しコード企業名
2020/05/0805 : 13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTMXCytomX Therapeutics Inc
2020/05/0805 : 10GlobeNewswire Inc.CytomX Therapeutics Announces First Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
2020/05/0521 : 00GlobeNewswire Inc.CytomX Therapeutics to Present at the 2020 Bank of America Securities Health Care ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
2020/04/3007 : 50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2020/04/3007 : 49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CTMXCytomX Therapeutics Inc
2020/04/3005 : 35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CTMXCytomX Therapeutics Inc
2020/04/3005 : 33Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CTMXCytomX Therapeutics Inc
2020/04/3005 : 05GlobeNewswire Inc.CytomX Therapeutics Announces Presentations at the 2020 American Society of Clinical Oncology Virtual Scientific ProgramNASDAQ:CTMXCytomX Therapeutics Inc
2020/04/2905 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
2020/04/2905 : 05GlobeNewswire Inc.CytomX Therapeutics Appoints Halley E. Gilbert to Board of DirectorsNASDAQ:CTMXCytomX Therapeutics Inc
2020/04/2721 : 00GlobeNewswire Inc.CytomX Therapeutics to Announce First Quarter 2020 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
2020/04/1805 : 31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CTMXCytomX Therapeutics Inc
2020/03/3105 : 28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
2020/03/3105 : 15GlobeNewswire Inc.CytomX Therapeutics Announces Milestone Achievement in AbbVie CD71 Partnership and Provides Update on Impact of COVID-19 on ...NASDAQ:CTMXCytomX Therapeutics Inc
2020/03/2605 : 10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
2020/03/2605 : 09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CTMXCytomX Therapeutics Inc
2020/03/2605 : 02GlobeNewswire Inc.CytomX Therapeutics Announces New Employment Inducement GrantNASDAQ:CTMXCytomX Therapeutics Inc
2020/03/2421 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
2020/03/2409 : 00GlobeNewswire Inc.CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop Probody® T-Cell Engaging Bispecific Therapies ...NASDAQ:CTMXCytomX Therapeutics Inc
2020/03/2406 : 26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
2020/03/2405 : 02GlobeNewswire Inc.CYTOMX THERAPEUTICS ANNOUNCES APPOINTMENT OF CARLOS CAMPOY AS CHIEF FINANCIAL OFFICERNASDAQ:CTMXCytomX Therapeutics Inc
2020/03/1705 : 23GlobeNewswire Inc.CytomX Therapeutics Announces New Employment Inducement GrantNASDAQ:CTMXCytomX Therapeutics Inc
2020/03/0707 : 30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTMXCytomX Therapeutics Inc
2020/02/2807 : 50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CTMXCytomX Therapeutics Inc
2020/02/2807 : 33Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CTMXCytomX Therapeutics Inc
2020/02/2807 : 09Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CTMXCytomX Therapeutics Inc
2020/02/2806 : 52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
2020/02/2806 : 28GlobeNewswire Inc.CytomX Therapeutics Announces Full-Year 2019 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
2020/02/2522 : 00GlobeNewswire Inc.CytomX Therapeutics to Present at Cowen and Company 40th Annual Health Care ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
2020/02/2422 : 00GlobeNewswire Inc.Bristol-Myers Squibb Advances CytomX Therapeutics’ Anti-CTLA-4 Probody Therapeutic BMS-986249 into Randomized Cohort Expans...NASDAQ:CTMXCytomX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTMX

最近閲覧した銘柄

LSE
GWP
Gw Pharmaceuticals
BIT
BRE
Brembo NV
NYSE
ERF
Enerplus
LSE
FLOT
Is $ Flt Rte Bd
LSE
SPED
Ivz Sp Eqw D
LSE
DPA
Dp Aircraft I
NASDAQ
SATC
NASDAQ
VCEL
Vericel
NYSE
AI
C3 AI
NYSE
LB
LandBridge
LSE
0NH5
Momina Krepost Ad
BIT
XLPS
Invesco Consumer Staples...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有